Fig. 1 · Structure
Documents & Downloads
Clervonafusp alfa
Cat. No.
A75211
CAS
2145123-44-8
Fusion Protein
Clervonafusp alfa is a fusion protein designed to target both cytosolic and lysosomal glycogen. It consists of the Fab portion of a cell-penetrating antibody that utilizes the nucleoside transporter ENT-2 for cytosolic access, along with recombinant human acid alpha-glucosidase (rhGAA) that enters lysosomes via mannose-6-phosphate receptors. This reagent is primarily used in research related to late-onset Pompe disease, facilitating studies on glycogen storage disorders and potential therapeutic approaches.
Select a Size
Selected package
Cat. No.
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2145123-44-8 |
| Applications | Fusion Protein |
| Synonyms | VAL-1221 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.